Cubist Systematic Strategies, LLC Astrazeneca PLC Transaction History

Cubist Systematic Strategies, LLC

$20.3 Billion
Q2 2025

A detailed history of Cubist Systematic Strategies, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 484,078 shares of AZN stock, worth $40.3 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

484,078

Previous 234,714 106.24%

Holding current value

$40.3 Million

Previous $17.3 Million 96.09%

% of portfolio

0.17%

Previous 0.11%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$64.87 - $75.0 $16.2 Million - $18.7 Million	249,364 Added 106.24%	484,078 $33.8 Million
Q1 2025 May 15, 2025	BUY	$65.37 - $77.96 $11.7 Million - $13.9 Million	178,792 Added 319.72%	234,714 $17.3 Million
Q4 2024 Feb 14, 2025	BUY	$63.2 - $79.58 $3.53 Million - $4.45 Million	55,922 New	55,922 $3.66 Million
Q1 2024 May 15, 2024	BUY	$61.03 - $69.57 $4.94 Million - $5.63 Million	80,863 Added 921.2%	89,641 $6.07 Million
Q4 2023 Feb 14, 2024	SELL	$61.89 - $69.28 $1.36 Million - $1.52 Million	-21,974 Reduced 71.46%	8,778 $591,000
Q3 2023 Nov 14, 2023	SELL	$64.85 - $71.7 $2.06 Million - $2.28 Million	-31,842 Reduced 50.87%	30,752 $2.08 Million
Q2 2023 Aug 14, 2023	SELL	$69.91 - $75.81 $411,699 - $446,445	-5,889 Reduced 8.6%	62,594 $4.48 Million
Q1 2023 May 15, 2023	BUY	$63.15 - $71.6 $3.59 Million - $4.07 Million	56,821 Added 487.23%	68,483 $4.75 Million
Q4 2022 Feb 14, 2023	SELL	$54.21 - $70.44 $968,407 - $1.26 Million	-17,864 Reduced 60.5%	11,662 $790,000
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $644,564 - $1.65 Million	12,157 Added 69.99%	29,526 $1.62 Million
Q2 2022 Aug 15, 2022	BUY	$59.26 - $71.14 $92,741 - $111,334	1,565 Added 9.9%	17,369 $1.15 Million
Q1 2022 May 16, 2022	BUY	$55.72 - $67.12 $37,109 - $44,701	666 Added 4.4%	15,804 $1.05 Million
Q4 2021 Feb 14, 2022	BUY	$54.02 - $63.83 $203,601 - $240,575	3,769 Added 33.15%	15,138 $882,000
Q3 2021 Nov 15, 2021	SELL	$55.56 - $60.79 $332,082 - $363,341	-5,977 Reduced 34.46%	11,369 $683,000
Q2 2021 Aug 16, 2021	SELL	$48.42 - $60.18 $2.81 Million - $3.5 Million	-58,077 Reduced 77.0%	17,346 $1.04 Million
Q1 2021 May 17, 2021	BUY	$47.16 - $54.44 $1.92 Million - $2.22 Million	40,691 Added 117.16%	75,423 $3.75 Million
Q4 2020 Feb 16, 2021	SELL	$48.52 - $58.02 $2.22 Million - $2.66 Million	-45,843 Reduced 56.89%	34,732 $1.74 Million
Q3 2020 Nov 16, 2020	BUY	$53.07 - $61.1 $1.4 Million - $1.61 Million	26,290 Added 48.43%	80,575 $4.42 Million
Q2 2020 Aug 14, 2020	BUY	$43.1 - $55.31 $2.26 Million - $2.9 Million	52,359 Added 2718.54%	54,285 $2.87 Million
Q1 2020 May 15, 2020	SELL	$37.79 - $51.33 $573,160 - $778,522	-15,167 Reduced 88.73%	1,926 $86,000
Q4 2019 Feb 14, 2020	BUY	$42.46 - $50.46 $725,768 - $862,512	17,093 New	17,093 $852,000
Q3 2019 Nov 14, 2019	SELL	$40.12 - $45.47 $421,821 - $478,071	-10,514 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$37.28 - $41.68 $4.81 Million - $5.38 Million	-128,959 Reduced 92.46%	10,514 $434,000
Q1 2019 May 15, 2019	BUY	$35.49 - $43.02 $4.59 Million - $5.56 Million	129,277 Added 1267.92%	139,473 $5.64 Million
Q4 2018 Feb 14, 2019	BUY	$36.86 - $41.49 $309,476 - $348,350	8,396 Added 466.44%	10,196 $387,000
Q3 2018 Nov 14, 2018	SELL	$34.76 - $39.72 $571,767 - $653,354	-16,449 Reduced 90.14%	1,800 $71,000
Q2 2018 Aug 14, 2018	SELL	$34.55 - $37.05 $279,025 - $299,215	-8,076 Reduced 30.68%	18,249 $641,000
Q1 2018 May 15, 2018	BUY	$32.97 - $36.63 $634,408 - $704,834	19,242 Added 271.66%	26,325 $921,000
Q4 2017 Feb 14, 2018	BUY	$32.09 - $34.78 $10,461 - $11,338	326 Added 4.82%	7,083 $246,000
Q3 2017 Nov 14, 2017	BUY	$28.96 - $34.0 $195,682 - $229,738	6,757	6,757 $229,000

Others Institutions Holding AZN

# of Institutions

1,442

Shares Held

498M

Call Options Held

7.22M

Put Options Held

2.57M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $258B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Astrazeneca PLC Transaction History